A phase II trial of omadacycline for the treatment of complicated urinary tract infections

Trial Profile

A phase II trial of omadacycline for the treatment of complicated urinary tract infections

Planning
Phase of Trial: Phase II

Latest Information Update: 03 Apr 2017

At a glance

  • Drugs Omadacycline (Primary)
  • Indications Urinary tract infections
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Paratek Pharmaceuticals
  • Most Recent Events

    • 03 Apr 2017 According to a Paratek Pharmaceuticals media release, company plans to begin enrolment as early as December of 2017.
    • 08 Feb 2017 According to a Paratek Pharmaceuticals media release, company plans to begin enrolment in the fourth quarter of 2017.
    • 06 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top